166 related articles for article (PubMed ID: 826814)
21. [SMON-- Japanese disease?].
Dölle W
Internist (Berl); 1971 Sep; 12(9):405-6. PubMed ID: 4938935
[No Abstract] [Full Text] [Related]
22. [SMON (subacute myelo-optico-neuropathy)].
Kaeser HE
Schweiz Rundsch Med Prax; 1972 Jul; 61(29):927-30. PubMed ID: 4655587
[No Abstract] [Full Text] [Related]
23. [Neurological complications in the course of treatment of acrodermatitis enteropathica with oxyquinoline derivatives].
Papuziński M; Wilmowska-Pietruszyńska A
Pediatr Pol; 1974 Nov; 49(11):1393-7. PubMed ID: 4278959
[No Abstract] [Full Text] [Related]
24. Neuropathology of subacute myelo-optico-neuropathy, "SMON".
Shiraki H
Jpn J Med Sci Biol; 1971 Aug; 24(4):217-43. PubMed ID: 5316312
[No Abstract] [Full Text] [Related]
25. [Toxicologic study on the etiology of SMON].
Ikeda Y
Nihon Rinsho; 1971 Feb; 29(2):766-72. PubMed ID: 5102709
[No Abstract] [Full Text] [Related]
26. Clinical features of SMON.
Toyokura Y; Takasu T
Jpn J Med Sci Biol; 1975; 28 Suppl():87-99. PubMed ID: 136544
[No Abstract] [Full Text] [Related]
27. [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation].
Inoue N; Kuroiwa Y; Ikeda M; Yasukouchi T
Rinsho Shinkeigaku; 1974 Oct; 14(10):769-73. PubMed ID: 4282713
[No Abstract] [Full Text] [Related]
28. [Subacute myelo-optico-neuropathy (SMON) in Japan. The question of chinoform poisoning].
Igata A; Toyokura Y
Munch Med Wochenschr; 1971 Jul; 113(31):1062-6. PubMed ID: 5109393
[No Abstract] [Full Text] [Related]
29. [Myelo-optico-neuropathy probably due to chloramphenicol--an autopsy case].
Nakamura Y; Ogata J; Watanabe T; Segawa J
Rinsho Shinkeigaku; 1976 Jan; 16(1):1-7. PubMed ID: 943259
[No Abstract] [Full Text] [Related]
30. [Clinical features of myeloneuropathy with abdominal disorders (SMON)].
Sobue I; Ando K
Nihon Ganka Kiyo; 1971 May; 22(5):291-3. PubMed ID: 5104937
[No Abstract] [Full Text] [Related]
31. [Subacute myelo-optico-neuropathy following use of large amounts of iodochlorhydroxyquinoline (Enterovioform)].
Bron HL; Korten JJ; Pinckers AJ; Majoor CL
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1615-8. PubMed ID: 4262825
[No Abstract] [Full Text] [Related]
32. Clioquinol intoxication occurring in the treatment of acrodermatitis enteropathica with reference to SMON outside of Japan.
Hanakago R; Uono M
Clin Toxicol; 1981 Dec; 18(12):1427-34. PubMed ID: 6460590
[TBL] [Abstract][Full Text] [Related]
33. [SMON syndrome].
Igata A
Nihon Rinsho; 1977; 35 Suppl 1():626-7. PubMed ID: 148526
[No Abstract] [Full Text] [Related]
34. [Polyneuropathy following long-term use of clioquinol (Enterovioform)].
van Beeck JA; Scholten JB
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1621-2. PubMed ID: 4262827
[No Abstract] [Full Text] [Related]
35. Assessment of neurotoxicity of clioquinol (Enterovioform) by visual evoked potentials. A preliminary communication.
Bhasin DK; Raina R; Mehta SK; Arora MM
Indian J Gastroenterol; 1985 Jul; 4(3):165-6. PubMed ID: 3160659
[No Abstract] [Full Text] [Related]
36. [Subacute myelo-optical neuropathy (SMON) in thallium poisoning].
Beer G; Schwartz RB
Nervenarzt; 1982 Aug; 53(8):451-4. PubMed ID: 7133245
[No Abstract] [Full Text] [Related]
37. Subacute myelo-optic neuropathy and the halogenated hydroxyquinolines.
Med J Aust; 1971 Nov; 2(21):1090-1. PubMed ID: 5127493
[No Abstract] [Full Text] [Related]
38. The neurotoxicity of the halogenated hydroxyquinolines. A commentary.
Oakley GP
JAMA; 1973 Jul; 225(4):395-7. PubMed ID: 4270059
[No Abstract] [Full Text] [Related]
39. [Aetiological and clinical study on subacute myelo-optico-neuropathy (SMON) (author's transl)].
Tsubaki T
Nihon Naika Gakkai Zasshi; 1974 Jan; 63(1):1-17. PubMed ID: 4856733
[No Abstract] [Full Text] [Related]
40. [Report on subacute-myelo-optico-neuropathy (SMON) by the Joint Study Unit. 2].
Iryo; 1971 Dec; 25(12):921-51. PubMed ID: 5147605
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
